PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 43 filers reported holding PSYCHEMEDICS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,887 | -8.3% | 340 | 0.0% | 0.00% | – |
Q1 2020 | $2,057 | -33.9% | 340 | 0.0% | 0.00% | – |
Q4 2019 | $3,111 | +0.5% | 340 | 0.0% | 0.00% | – |
Q3 2019 | $3,097 | +34.0% | 340 | +48.5% | 0.00% | – |
Q2 2019 | $2,311 | +18.5% | 229 | +64.7% | 0.00% | – |
Q1 2019 | $1,950 | -11.6% | 139 | 0.0% | 0.00% | – |
Q4 2018 | $2,206 | – | 139 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
22NW, LP | 274,418 | $1,089,439 | 0.78% |
WEALTH EFFECTS LLC | 40,701 | $161,582 | 0.08% |
Cannell Capital | 74,794 | $296,932 | 0.07% |
SANTA MONICA PARTNERS LP | 20,000 | $79 | 0.06% |
RBF Capital, LLC | 144,231 | $572,597 | 0.04% |
WEDBUSH SECURITIES INC | 42,414 | $168 | 0.01% |
Ancora Advisors LLC | 78,373 | $311,141 | 0.01% |
Your Advocates Ltd., LLP | 1,400 | $5,558 | 0.00% |
CRAWFORD INVESTMENT COUNSEL INC | 32,098 | $127,428 | 0.00% |
Renaissance Technologies | 273,663 | $1,086 | 0.00% |